In Prospera, the Bitcoin and crypto-friendly free trade zone in Honduras, Vitalia: the “City of Life” is launching with the support of some crypto celebrities. The inaugural conference brings crypto, medical research and the pharmaceutical industry closer together than ever before.
It is no longer a secret that many well-known figures in the crypto scene are enthusiastic about “Longevity”, a relatively young industry that has made it its bold mission to radically extend life or even defeat death entirely.
In Prospera, a free trade zone in Honduras, Central America, crypto and longevity are currently coming closer together than ever before. On the island of Roatan, where Prospera is located, “Vitalia” is being built – a city in which longevity researchers and investors will work and live together, free from the pressure of regulation.
The founder of Vitalia is Laurence Ion, who as co-founder of VitaDAO has a foot in both the crypto space and the longevity industry. The core idea, starting with Prospera, is to create a network of free cities where doctors, biohackers, pharmaceutical researchers, investors, engineers and programmers will find the optimal conditions to research how to extend life.
In Vitalia there are coworking spaces, shared apartments and laboratories, healthy food, fitness studios, wellness – and the option to be part of a pure crypto economy. It should be 100 percent possible to cover your expenses with cryptocurrencies. Since the tax authorities in Prospera also allow taxes to be paid with Bitcoin, this should not be an empty promise.
One thesis behind Vitalia is that the over-regulation of the pharmaceutical and healthcare industries is increasingly delaying medical breakthroughs. Computer simulations and artificial intelligence could radically accelerate the development of new, life-extending drugs, but regulatory requirements mean that it usually takes more than ten years between the breakthrough in the laboratory and approval. There is an increasing gap between technical and bureaucratic reality.
In Vitalia, “the development of drugs should be accelerated to warp speed: from more than ten years to four months to market readiness.” If it is not possible to “solve the problem of overregulation, it will be extremely difficult to bring aging under medical control get as long as we live.” The last sentence in particular is likely to be crucial for many investors who have accumulated considerable wealth but are already in the autumn of their lives.
The speakers at a series of conferences that Vitalia is opening with in January and February show how closely longevity and crypto are intertwined. In addition to well-known longevity researchers and representatives from pharmaceutical companies such as Pfizer and Novartis, you can find Vitalik Buterin from Ethereum, Brian Armstrong from Coinbase, representatives from several DAOs – SynapseDAO, MoleculeDAO and multiple VitaDAO – Ben Goertzel from SingularityNET and many others. Maximon, the longevity fund from Bitcoin investor Marc Bernegger, is also represented.
What is particularly noteworthy is the strong presence of medical DAOs. While the decentralized autonomous organizations have so far barely been able to gain a foothold outside of DeFi, they appear to be establishing themselves in the financing of avant-garde medical research projects.